Friday, April 7, 2017

Medtronic Announces Voluntary Worldwide Recall of its Stratamr Adjustable Valves and Shunts - FDA Safety Alerts & Drug Recalls

Medtronic plc (NYSE: MDT) today announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR adjustable valves and shunts. These products are manufactured and marketed by Medtronic's Neurosurgery business, which is part of the Brain Therapies division of the company's Restorative Therapies Group.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2obagJ7
via IFTTT

No comments:

Post a Comment